Sector Investment 3 Days

Last updated: August 21, 2026, 11:18 PM ET

Healthcare Private Equity

Healthcare deal-making showed no signs of cooling this week. SkyKnight Capital has entered into a definitive agreement to invest in Apex Infusion, deepening private equity's push into the fast-growing infusion services segment. In a far larger transaction, a Warburg Pincus-led investor group agreed to acquire a controlling interest in PANTHERx Rare, the rare-disease pharmacy specialist, in a deal valued at $7bn — among the year's biggest healthcare buyouts and a signal of sustained appetite for specialty pharma platforms.

AI Infrastructure

Nvidia and its partners have pledged $500bn to establish compute as a new "investable" infrastructure asset class, though the open question is whether institutional allocators will treat AI facilities with the same conviction as toll roads or power grids. A companion analysis frames the buildout as a virtuous circle linking energy and digital assets, arguing that power availability will ultimately determine how much of the $500bn pipeline converts into deployable deals.

Renewables Fundraising

Fundraising momentum persisted despite geopolitical turbulence. CIP reached a $3bn final close for its second growth-markets renewables strategy, drawing strong re-commitments from existing limited partners even as emerging-market headwinds tested new capital formation.

Pension Allocations

Slower deployment is visible on the allocator side. South Korea's National Pension Service grew its infrastructure AUM by just 13.4% in 2024, a marked deceleration from the 24.2% expansion recorded in 2023 — a cautionary datapoint for managers counting on pension capital to absorb mega-deals.